![](/img/cover-not-exists.png)
Long-term treatment with evolocumab homozygous familial hypercholesterolemia patients: Results from the trial assessing long-term use of PCSK9 inhibition in subjects with genetic LDL disorders (Taussig)
Stein, E.A., Sampietro, T., Santos, R., Harada-Shiba, M., Bruckert, E., Blom, D., Hovingh, G.K., Couture, P., Blaha, V., Farnier, M., Descamps, O., Soran, H., Kasichayanula, S., Gibbs, J., Kurtz, C.,Volume:
252
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2016.07.374
Date:
September, 2016
File:
PDF, 53 KB
english, 2016